MediPharm Labs Corp. Acquires VIVO Cannabis Inc.
April 1, 2023
Effective April 1, 2023, MediPharm Labs Corp. completed an all-equity arrangement to acquire all outstanding shares of VIVO Cannabis Inc., making VIVO a wholly-owned subsidiary. Under the arrangement, former VIVO shareholders received 0.2910 MediPharm common shares per VIVO share and MediPharm issued approximately 107,930,964 shares as consideration; VIVO shares are expected to be delisted from the Toronto Stock Exchange.
- Buyers
- MediPharm Labs Corp.
- Targets
- VIVO Cannabis Inc.
- Sellers
- Former VIVO shareholders
- Industry
- Pharmaceuticals
- Location
- Ontario, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Vivo Infusion Acquires Specialty Infusion
June 20, 2023
Healthcare Services
Vivo Infusion, a national provider of community-based ambulatory infusion and injection care, has acquired Specialty Infusion, a provider of ambulatory infusion and specialty pharmacy services operating 14 centers across New York, Massachusetts, and New Jersey. The deal expands Vivo's footprint to a combined 55 ambulatory infusion centers across ten states; financial terms were not disclosed.
-
Vivo Infusion Acquires CIVIC Infusion
January 31, 2023
Healthcare Services
Vivo Infusion, a provider of community-based ambulatory infusion services, has acquired CIVIC Infusion, which operates infusion centers in Connecticut and New York. CIVIC co-founders Drs. Barry Stein and Robert Roteman will join Vivo as Medical Directors; the combined organization now reaches 36 ambulatory infusion centers across nine states. Financial terms were not disclosed.
-
Revive Therapeutics Agrees to Acquire Psilocin Pharma Corp.
February 11, 2020
Pharmaceuticals
Revive Therapeutics Ltd. entered into a letter of intent to acquire all issued and outstanding securities of Psilocin Pharma Corp. for an aggregate purchase price of $2.75 million to be satisfied by issuing 55 million common shares of Revive (deemed $0.05/share). Revive deposited 10 million shares ($500,000) into escrow as a deposit; the closing is subject to due diligence and execution of a definitive share exchange agreement.
-
Vivo Infusion (InTandem-backed) Acquires Infusion Center of Pennsylvania
September 15, 2022
Healthcare Services
Vivo Infusion, a portfolio company of InTandem Capital Partners, has acquired Infusion Center of Pennsylvania (ICPA), the largest non-hospital infusion provider in the greater Philadelphia region. The add-on expands Vivo's footprint into Pennsylvania and New Jersey and adds home infusion and specialty pharmacy capabilities to its ambulatory infusion platform.
-
PharmaCann Acquires LivWell Enlightened Health
February 28, 2022
Retail
PharmaCann Inc. has completed its previously announced acquisition of LivWell Holdings, Inc., combining the two vertically integrated cannabis operators into a platform with over 50 dispensaries and 10 cultivation/production facilities across eight U.S. states. The transaction expands PharmaCann's presence into Colorado and Michigan; LivWell founder and CEO John Lord will join the PharmaCann board.
-
Vivo Infusion Acquires Infusion Associates from Boyne Capital
July 9, 2024
Healthcare Services
Vivo Infusion, a national provider of community-based ambulatory infusion and injection services, has acquired Infusion Associates, a Midwest-focused ambulatory infusion operator headquartered in Grand Rapids, Michigan. The deal—sold by Boyne Capital and supported by Vivo's investor InTandem Capital Partners—adds Infusion Associates' 14 locations in Michigan, Minnesota, Ohio and Wisconsin to the Vivo platform as it nears management of ~80 centers across 15 states; financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.